In an era where health data often lives in silos, Aeon is building a unified platform to bring clarity to individual health, and it just secured a significant financial boost. The company, which integrates comprehensive MRI, blood markers, and genetics into a single, longitudinal health platform, has closed a $13.9M Seed round.
Aeon aims to deliver unmatched precision in early detection and empower continuous health monitoring, leveraging AI modeling to boost diagnostic precision and reduce costs, making cutting-edge preventive care more accessible. The round saw participation from Arāya Ventures, Concentric, GoHub Ventures, Kadmos Capital, Calm/Storm, N&V Capital, and Daniel Gutenberg.


















